Health Scope

Published by: Kowsar

Effects of a Traditional Iranian Remedy on Cutaneous Leishmaniasis

Masoud Maleki 1 , Mahdi Yousefi 2 , Sayyed Abolghassem Sajadi Tabassi 3 , Hassan Rakhshandeh 3 , Sayyed Mojtaba Mousavi Bazzaz 4 , Gholamreza Haghighi 5 , 6 , * , Shokouh Sadat Hamedi 7 , Sayyed Abdolrahim Rezaee 8 and Fatemeh Haghighi 9
Authors Information
1 Cutaneous Leishmaniasis Research Center, Department of Dermatology, Mashhad University of Medical Sciences, Mashhad, Iran
2 Department of Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3 Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran
4 Department of Social Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
5 School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
6 Zabol Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol, Iran
7 Department of Persian Pharmacy, School of Persian and Complementary Medicine, Mashhad, Iran
8 Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
9 Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Article information
  • Health Scope: August 2018, 7 (3); e61206
  • Published Online: August 19, 2018
  • Article Type: Research Article
  • Received: September 2, 2017
  • Accepted: October 9, 2017
  • DOI: 10.5812/jhealthscope.61206

To Cite: Maleki M, Yousefi M, Sajadi Tabassi S A, Rakhshandeh H, Mousavi Bazzaz S M, et al. Effects of a Traditional Iranian Remedy on Cutaneous Leishmaniasis, Health Scope. 2018 ; 7(3):e61206. doi: 10.5812/jhealthscope.61206.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Paniker CKJ, Ghosh S. Paniker's Textbook of medical parasitology. 7th ed. Jaypee Brothers Pvt. Limited; 2013.
  • 2. Bolognia JL, Jorizzo JL, Schaffer JV. Dermatology. 3rd ed. Elsevier Saunders; 2012.
  • 3. Word Health Organization. Leishmaniasis: Fact Sheet N 375. Geneva; 2015. Available from: http://www.who.int/news-room/fact-sheets/detail/leishmaniasis.
  • 4. Asilian A, Jalayer T, Whitworth JA, Ghasemi RL, Nilforooshzadeh M, Olliaro P. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. Am J Trop Med Hyg. 1995;53(6):648-51. [PubMed: 8561269].
  • 5. Reithinger R, Mohsen M, Aadil K, Sidiqi M, Erasmus P, Coleman PG. Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan. Emerg Infect Dis. 2003;9(6):727-9. doi: 10.3201/eid0906.030026. [PubMed: 12781016]. [PubMed Central: PMC3000158].
  • 6. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305-18. doi: 10.1016/j.cimid.2004.03.004. [PubMed: 15225981].
  • 7. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis. 1997;24(4):684-703. [PubMed: 9145744].
  • 8. Pourmohammadi B, Motazedian MH, Handjani F, Hatam GH, Habibi S, Sarkari B. Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis. Southeast Asian J Trop Med Public Health. 2011;42(3):502-8. [PubMed: 21706927].
  • 9. Bailey MS, Lockwood DN. Cutaneous leishmaniasis. Clin Dermatol. 2007;25(2):203-11. doi: 10.1016/j.clindermatol.2006.05.008. [PubMed: 17350500].
  • 10. Sharquie KE, Najim RA, Farjou IB. A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis. Clin Exp Dermatol. 1997;22(4):169-73. [PubMed: 9499605].
  • 11. Maleki M, Karimi G, Tafaghodi M, Raftari S, Nahidi Y. Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis. Indian J Dermatol. 2012;57(2):118-22. doi: 10.4103/0019-5154.94279. [PubMed: 22615508]. [PubMed Central: PMC3352633].
  • 12. Haghighi G, Maleki M, Rakhshandeh H, Yusofi M. Treatment of cutaneous leishmaniasis using berberis vulgaris: a case report. Avicenna J Phytomedicine. 2015;5.
  • 13. Bayan L, Koulivand PH, Gorji A. Garlic: a review of potential therapeutic effects. Avicenna J Phytomed. 2014;4(1):1-14. [PubMed: 25050296]. [PubMed Central: PMC4103721].
  • 14. Mukherjee PK, Nema NK, Bhadra S, Mukherjee D, Braga FC, Matsabisa MG. Immunomodulatory leads from medicinal plants. Indian J Tradition Knowl. 2014;13(2):235-56.
  • 15. Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect. 1999;1(2):125-9. [PubMed: 10594976].
  • 16. Gaafar MR. Efficacy of Allium sativum (garlic) against experimental cryptosporidiosis. Alexandria J Med. 2012;48(1):59-66. doi: 10.1016/j.ajme.2011.12.003.
  • 17. Lun ZR, Burri C, Menzinger M, Kaminsky R. Antiparasitic activity of diallyl trisulfide (dasuansu) ou human and animal pathogenic protozoa (trypanosoma sp., entamoeba histolytica and giardia lamblia) in vitro. Annales-Societe Belge De Medecine Tropicale. Institute of Tropical Medicine; 1994. 51 p.
  • 18. Fliermans CB. Inhibition of Histoplasma capsulatum by garlic. Mycopathol Mycol Appl. 1973;50(3):227-31. [PubMed: 4729537].
  • 19. Zargari A. Medicinal Herbs Book. Tehran: Tehran University Publications; 2011.
  • 20. Arreola R, Quintero-Fabian S, Lopez-Roa RI, Flores-Gutierrez EO, Reyes-Grajeda JP, Carrera-Quintanar L, et al. Immunomodulation and anti-inflammatory effects of garlic compounds. J Immunol Res. 2015;2015:401630. doi: 10.1155/2015/401630. [PubMed: 25961060]. [PubMed Central: PMC4417560].
  • 21. Shirazi MHAAK. Makhzan ol-Advieh. Tehran: Publications and Training of Islamic Revolution; 1992. 1032 p.
  • 22. Avicenna . al-Qanun fi Tibb. Beirut: Dar ol maktabat ol helal; 2009.
  • 23. Nafis E. Al-Shamel fi Al-senaat e Tebiie. Tehran: Iran University Of Medical Science; 2008.
  • 24. Hajjaran H, Mohebali M, Razavi MR, Rezaei S, Kazemi B, Edrissian GH, et al. Identification of leishmania species isolated from human cutaneous leishmaniasis, using random amplified polymorphic DNA (RAPD-PCR). Iran J Public Health. 2004;33(4):8-15.
  • 25. Tuon FF, Amato VS, Graf ME, Siqueira AM, Nicodemo AC, Amato Neto V. Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis. Int J Dermatol. 2008;47(2):109-24. doi: 10.1111/j.1365-4632.2008.03417.x. [PubMed: 18211479].
  • 26. Fatima F, Khalid A, Nazar N, Abdalla M, Mohomed H, Toum AM, et al. In vitro assessment of anti - cutaneous leishmaniasis activity of some Sudanese plants. Turkiye Parazitol Derg. 2005;29(1):3-6. [PubMed: 17167733].
  • 27. Ghazanfari T, Hassan ZM, Khamesipour A. Enhancement of peritoneal macrophage phagocytic activity against Leishmania major by garlic (Allium sativum) treatment. J Ethnopharmacol. 2006;103(3):333-7. doi: 10.1016/j.jep.2005.08.026. [PubMed: 16213117].
  • 28. Ghazanfari T, Hassan ZM, Ebtekar M, Ahmadiani A, Naderi G, Azar A. Garlic induces a shift in cytokine pattern in Leishmania major-infected BALB/c mice. Scand J Immunol. 2000;52(5):491-5. [PubMed: 11119248].
  • 29. Khoshzaban F, Ghaffarifar F, Mahmmoudzadeh Poornaki A, Ghazanfari T, Naseri M, Khmesipoor A, et al. [Evaluation treatment of cutaneous Leishmaniasis with Garlic extract and R10 fraction in BALB/c, C57BL/6 and outbred SW mice]. Modarres J Med Sci Biologic Pathol. 2011;14(3):25-34. Persian.
  • 30. Samdani A, Samreen J, Iqbal Choudhary M, Atta R. Laboratory studies and clinical trials on new formulations from garlic extract against cutaneous leishmaniasis. Anti-Infective Agents. 2012;10(2):111-6. doi: 10.2174/2211362611208020111.
  • 31. Khalid NM, Mohomed HE, Toum AM, Mubark MA, Magzoub MA. Treatment of cutaneous leishmaniasis with some local sudanese plants (Neem, Garad and Garlic). Türkiye Parazitoloji Dergisi. 2004;28(3):129-32.
  • 32. Gholami AR, Khamesipour A, Momeni A, Ghazanfari T, Nilforoushzadeh MA, Darajeh Z, et al. Treatment of cutaneous leishmaniasis with 5% garlic cream: A randomized, double-blind study. Iran J Dermatology. 2000;3(11):2-6.
  • 33. Babaee Khou L, Mohebali M, Lahiji N, Mehrabi Tavana A. [The therapeutic effects of Eucalyptus, Myrtus, Ferula, Aretmisia, Allium and Urtica extracts against cutaneous leishmaniasis caused by Leishmanaia major in small white mice (out-bred)]. Hakim Res J. 2007;10(2):21-7. Persian.
  • 34. Soto J, Rojas E, Guzman M, Verduguez A, Nena W, Maldonado M, et al. Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis. Clin Infect Dis. 2013;56(9):1255-60. doi: 10.1093/cid/cit049. [PubMed: 23390069].
  • 35. Monge-Maillo B, Lopez-Velez R. Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis. Drugs. 2013;73(17):1889-920. doi: 10.1007/s40265-013-0132-1. [PubMed: 24170665].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments